DNA topoisomerase inhibitors.
Capranico
G
G
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.
Giaccone
G
G
Zunino
F
F
Garattini
S
S
D'Incalci
M
M
D002470:Cell Survival / Q000187:drug effects; D002869:Chromosome Aberrations / Q000139:chemically induced*; D025063:Chromosome Disorders; D017321:Clinical Trials, Phase I as Topic; D004264:DNA Topoisomerases, Type I / Q000235:genetics / Q000502:physiology; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D009369:Neoplasms / Q000201:enzymology / Q000235:genetics; D059004:Topoisomerase I Inhibitors
D004791:Enzyme Inhibitors; D059004:Topoisomerase I Inhibitors; D004264:DNA Topoisomerases, Type I